Symbiox Investment Statements
53
Symbiox Investment Income Statement
B
M
INR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
13.042
13.102
-0.06
—
0.708
1.62
-1.68
—
0.849
-0.831
-0.466
-0.365
-0.012
30.278
25.937
100
21.646
80.7
4.291
19.3
—
0
1.029
4.5
2.436
7.3
1.855
11.9
—
0
1.451
2.4
3.306
14.4
0.859
-3.7
2.447
18.1
0.078
31.399
2.282
100
6.817
-174.9
-4.535
274.9
—
0
0.91
-56.9
3.441
-210.4
-7.976
485.2
—
0
1.31
-11.2
-6.666
474
2.074
-123.02
-8.74
597.1
-0.279
31.277
57.525
100
44.625
78.9
12.9
21.1
—
0
1.524
3.1
3.374
6.4
9.526
14.7
—
0
6.259
12.6
15.785
27.3
3.913
6.5
11.872
20.8
0.38
31.248
8.392
100
9.143
111.8
-0.752
-11.8
—
0
0.855
16.8
2.684
45
-3.436
-56.7
-0.001
-0.03
2.52
-10.2
-0.917
-67
-0.284
-16.5
-0.633
-50.5
-0.02
31.426
2.137
100
1.804
84.4
0.333
15.6
—
0
0.775
19.9
2.918
80.1
-2.585
-64.5
—
0
5.379
186.9
2.794
122.4
0.772
34
2.022
88.4
0.064
32.262
19.698
100
24.404
123.9
-4.706
-23.9
—
0
0.828
2.3
3.128
13.5
-7.834
-37.4
—
0
7.892
34.4
0.058
-3.008
0.015
-0.8
0.043
-2.2
0.001
30.303
1.089
100
0.954
87.6
0.135
12.4
—
0
0.655
29.9
1.482
41
-1.347
-28.6
—
0
2.228
96.5
0.881
68
0.23
17.7
0.651
50.2
0.021
32.962
10.38
100
15.413
148.5
-5.034
-48.5
—
0
0.663
2.2
2.957
17.6
-7.991
-66.1
—
0
6.67
62.2
-1.321
-4
-0.347
-3.3
-0.974
-0.6
-0.031
31.338
—
100
—
0
—
0
—
0
0.685
0
1.284
0
-1.284
0
—
0
2.922
0
1.638
0
0.426
0
1.212
0
0.038
32.332
8.973
100
14.375
160.2
-5.402
-60.2
—
0
0.909
7.6
1.428
11.5
-6.83
-71.7
—
0
5.702
55.1
-1.128
-16.6
-0.287
-4.2
-0.841
-12.3
-0.027
31.181
—
100
—
0
—
0
—
0
0.6
0
1.32
0
-1.32
0
—
0
2.82
0
1.5
0
0.39
0
1.11
0
0.03
31.28